Patients with high levels of GH, GH nadir, and IGF-1 were more likely to develop hypogonadism, with GH/IGF-1 inhibition on the hypothalamic-pituitary-gonadal axis being a possible etiology (20, 21). The gene discussed is GH1; the disease is hypogonadism.